During the past decade, Hematology Center after Prof. R. Yeolyan conducted 4 clinical trials. In the 10-year time frame, 4 clinical trials started and 1 clinical trials were completed, i.e. on average, 25% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 1 clinical trials were completed. i.e. 33.3% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Hematology Center after Prof. R. Yeolyan" #1 collaborator was "European Network of Gynaecological Oncological Trial Groups (ENGOT)" with 1 trials as a collaborator and "Hematology Center after Prof. R. Yeolyan" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 2 trials.

According to Clinical.Site data, the most researched conditions in "Hematology Center after Prof. R. Yeolyan" are "Hemophilia A With Inhibitor" (2 trials), "Hemophilia B With Inhibitor" (2 trials), "Advanced Cancer" (1 trials), "Metastatic Cervical Cancer" (1 trials) and "Oral Mucositis" (1 trials). Many other conditions were trialed in "Hematology Center after Prof. R. Yeolyan" in a lesser frequency.

Most popular intervention types in "Hematology Center after Prof. R. Yeolyan" are "Biological" (2 trials), "Drug" (2 trials) and "Device" (1 trials). Other intervention types were less common.

The name of intervention was led by "Balstilimab (BAL)" (1 trials), "Benzydamine" (1 trials), "Bocaliner" (1 trials), "Coagulation Factor VIIa variant" (1 trials) and "Gemcitabine" (1 trials). Other intervention names were less common.

The vast majority of trials in "Hematology Center after Prof. R. Yeolyan" are 2 trials for "All" genders, 1 trials for "Female" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Hematology Center after Prof. R. Yeolyan". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 1 completed trials in Hematology Center after Prof. R. Yeolyan, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Hematology Center after Prof. R. Yeolyan, 1 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".